Skip to main content

11 Result(s)

within K Moser Remove this filter English Remove this filter Oncology Remove this filter

and

  1. Article

    Open Access

    Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase

    Lactate dehydrogenase (LDH) in serum has recently been introduced into the American Joint Committee on Cancer (AJCC) staging system for cutaneous melanoma because of its prognostic value. We hypothesised LDH t...

    M Deichmann, B Kahle, K Moser, J Wacker, K Wüst in British Journal of Cancer (2004)

    Download PDF (113 KB) View Article

  2. No Access

    Article

    Successful immunotherapy in early relapse of acute myeloid leukemia after nonmyeloablative allogeneic stem cell transplantation

    We report on a 35-year-old woman who underwent allogeneic stem cell transplantation (SCT) in second complete remission (CR) of acute myeloid leukemia (AML) after reduced-intensity conditioning with fludarabine...

    E. Prinz, F. Keil, P. Kalhs, M. Mitterbauer, W. Rabitsch… in Annals of Hematology (2003)

  3. No Access

    Article

    Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants

    We analyzed toxicity and efficacy of chemotherapy (CT) or second stem cell transplantation (SCT) and/or immunotherapy defined as stop of immunosuppression (IS) or donor leukocyte infusion (DLI) in 47 patients ...

    F Keil, E Prinz, P Kalhs, K Lechner, K Moser, I Schwarzinger, U Jäger… in Leukemia (2001)

  4. No Access

    Article

    Hematopoietic donor chimerism and graft-versus-myeloma effect in relapse of multiple myeloma after allogeneic bone marrow transplantation

     A large group of patients relapsing after allogeneic bone marrow transplantation (BMT) have obtained remission after infusion of leukocytes from their original donor, suggesting a graft-versus-myeloma effect....

    F. Keil, P. Kalhs, X. Chen, O. A. Haas, G. Fritsch, A. Chott… in Annals of Hematology (1999)

  5. No Access

    Article

    Toxicity and response to high-dose ifosfamide+mesna as salvage therapy for advanced breast cancer

    Twenty-six cycles of high-dose ifosfamide+mesna (HD-IFO+M) were applied to seven female patients with advanced breast cancer refractory to prior treatment, using three different durations of continuous infusio...

    G. G. Steger, C. Dittrich, O. Schlappack… in Journal of Cancer Research and Clinical On… (1988)

  6. Article

    Results of a four-year prospective randomised study of operable breast cancer

    R. Kolb, K. Kühnl-Brady, R. Jakesz, K. Moser… in Journal of Cancer Research and Clinical On… (1986)

    Download PDF (128 KB)

  7. No Access

    Article

    The human tumour cloning assay in the management of breast cancer patients

    A tumour cloning system was used to cultivate breast cancer specimens. Fifty-six percent of 87 samples were adequate for evaluation, showing clonal growth in about one third (35%). Effusions yielded significan...

    C Dittrich, R Jakesz, F Wrba, L Havelec, O Haas, J Spona… in British Journal of Cancer (1985)

  8. No Access

    Article

    Acute cardiac toxicity in patients after doxorubicin treatment and the effect of combined tocopherol and nifedipine pretreatment

    In two groups of female patients with metastatic breast cancer who had all been pretreated with doxorubicin (350 mg/m2), acute cardiac effects following i.v. doxorubicin bolus injection (60 mg/m2) were recorded o...

    R. Lenzhofer, U. Ganzinger, H. Rameis… in Journal of Cancer Research and Clinical On… (1983)

  9. No Access

    Article

    Noninvasive methods for the early detection of doxorubicin-induced cardiomyopathy

    Ninety-eight female patients (mean age 54 years) who underwent doxorubicin therapy because of metastatic breast cancer were submitted to radionuclide angiography at rest. Left ventricular ejection fractions (L...

    R. Lenzhofer, R. Dudczak, G. Gumhold… in Journal of Cancer Research and Clinical On… (1983)

  10. No Access

    Article

    The value of prognostic parameters for the stratification of advanced breast cancer patients

    One hundred seventy-five patients with metastatic breast cancer, treated with a combination chemotherapy (Cooper regimen), were analyzed retrospectively to identify the value of the traditional prognostic para...

    R. Mörz, M. Francesconi, M. Schemper… in Journal of Cancer Research and Clinical On… (1982)

  11. No Access

    Chapter

    Sialyl Transferase Activity: A Serum Enzyme Marker in the Follow-Up of Cancer Patients

    Changed activities of glycosyl transferases are thought to correlate with malignant degeneration of cells. This was found by examination of serum samples of cancer patients [1, 9, 10]. Particular importance is...

    U. Ganzinger, K. Moser in Adjuvant Therapies and Markers of Post-Sur… (1979)